Rafael Fonseca

40PUBLICATIONS
171CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Radiation therapyCellular immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (40)

|Sep 12, 2026
Prophylactic dexamethasone at the time of absolute lymphocyte expansion does not mitigate risk or event-free survival for immune effector cell associated delayed neurotoxicity.

|Jul 22, 2026
FcRH5×CD3 bispecific antibody cevostamab in relapsed or refractory multiple myeloma: a phase 1 trial.

|Jun 26, 2026
Early Treatment Failure in Patients Receiving Ciltacabtagene-Autoleucel for Relapsed/Refractory Multiple Myeloma.

|Jun 11, 2026
Clinical Evaluation of Ex Vivo Expanded MUC1-Specific Peripheral Blood T Cells for Adoptive Immunotherapy in Relapsed/Refractory Multiple Myeloma.

|Apr 22, 2026
A multicenter study of progression risk and outcomes in solitary bone plasmacytoma with and without marrow involvement.

|Apr 10, 2026
Diagnosis and management of immune effector cell-associated enterocolitis after ciltacabtagene autoleucel.

Kenneth Jc Lim, Hee Eun Lee, Zongming Eric Chen

Pageof 7

Frequent Collaborators

20 joint publications

P Leif Bergsagel

16 joint publications

Shaji Kumar

9 joint publications

Morie Gertz

8 joint publications

Sikander Ailawadhi